APO Research
Talk to an analyst

APO RESEARCH · REPORT

Candidiasis Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Candidiasis Drug Market Analysis and Forecast 2026-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchCandidiasis Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Candidiasis Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Candidiasis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Candidiasis Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Candidiasis Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Candidiasis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Candidiasis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Candidiasis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Candidiasis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Candidiasis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Candidiasis Drug include Bristol-Myers Squibb, Cisen Pharmaceutical, Effik, Kingyork Group, Perrigo, Bayer, Pfizer, J & J and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Candidiasis Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Candidiasis Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Candidiasis Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Candidiasis Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Candidiasis Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Candidiasis Drug revenue, projected growth trends, production technology, application and end-user industry.

Candidiasis Drug Segment by Company

Bristol-Myers Squibb

Cisen Pharmaceutical

Effik

Kingyork Group

Perrigo

Bayer

Pfizer

J & J

Sanofi

Teva

Candidiasis Drug Segment by Type

Oral

External Use

Other

Candidiasis Drug Segment by Application

Hospital

Retail Pharmacy

Other

Candidiasis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candidiasis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Candidiasis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candidiasis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Candidiasis Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Candidiasis Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Candidiasis Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Candidiasis Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Player Table 3. External Use Major Player Table 4. Other Major Player Table 5. Global Candidiasis Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Retail Pharmacy Major Player Table 8. Other Major Player Table 9. Candidiasis Drug Industry Trends Table 10. Candidiasis Drug Industry Drivers Table 11. Candidiasis Drug Industry Opportunities and Challenges Table 12. Candidiasis Drug Industry Restraints Table 13. Global Candidiasis Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Candidiasis Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Candidiasis Drug Market Share by Region (2021-2026) Table 16. Global Candidiasis Drug Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Candidiasis Drug Market Share by Region (2027-2032) Table 18. Global Candidiasis Drug Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Candidiasis Drug Revenue Market Share by Players (2021-2026) Table 20. Global Candidiasis Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Candidiasis Drug Key Players Headquarters & Area Served Table 22. Global Candidiasis Drug Players, Product Type & Application Table 23. Global Candidiasis Drug Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Candidiasis Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Candidiasis Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Candidiasis Drug Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Candidiasis Drug Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Candidiasis Drug Revenue Market Share by Type (2021-2026) Table 30. Global Candidiasis Drug Revenue Market Share by Type (2027-2032) Table 31. Global Candidiasis Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Candidiasis Drug Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Candidiasis Drug Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Candidiasis Drug Revenue Market Share by Application (2021-2026) Table 35. Global Candidiasis Drug Revenue Market Share by Application (2027-2032) Table 36. Bristol-Myers Squibb Company Information Table 37. Bristol-Myers Squibb Business Overview Table 38. Bristol-Myers Squibb Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Bristol-Myers Squibb Candidiasis Drug Product Portfolio Table 40. Bristol-Myers Squibb Recent Development Table 41. Cisen Pharmaceutical Company Information Table 42. Cisen Pharmaceutical Business Overview Table 43. Cisen Pharmaceutical Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Cisen Pharmaceutical Candidiasis Drug Product Portfolio Table 45. Cisen Pharmaceutical Recent Development Table 46. Effik Company Information Table 47. Effik Business Overview Table 48. Effik Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Effik Candidiasis Drug Product Portfolio Table 50. Effik Recent Development Table 51. Kingyork Group Company Information Table 52. Kingyork Group Business Overview Table 53. Kingyork Group Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Kingyork Group Candidiasis Drug Product Portfolio Table 55. Kingyork Group Recent Development Table 56. Perrigo Company Information Table 57. Perrigo Business Overview Table 58. Perrigo Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Perrigo Candidiasis Drug Product Portfolio Table 60. Perrigo Recent Development Table 61. Bayer Company Information Table 62. Bayer Business Overview Table 63. Bayer Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bayer Candidiasis Drug Product Portfolio Table 65. Bayer Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Pfizer Candidiasis Drug Product Portfolio Table 70. Pfizer Recent Development Table 71. J & J Company Information Table 72. J & J Business Overview Table 73. J & J Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. J & J Candidiasis Drug Product Portfolio Table 75. J & J Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Sanofi Candidiasis Drug Product Portfolio Table 80. Sanofi Recent Development Table 81. Teva Company Information Table 82. Teva Business Overview Table 83. Teva Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Teva Candidiasis Drug Product Portfolio Table 85. Teva Recent Development Table 86. North America Candidiasis Drug Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Candidiasis Drug Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Candidiasis Drug Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Candidiasis Drug Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Candidiasis Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Candidiasis Drug Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Candidiasis Drug Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Candidiasis Drug Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Candidiasis Drug Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Candidiasis Drug Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Candidiasis Drug Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Candidiasis Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Candidiasis Drug Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Candidiasis Drug Revenue by Country (US$ Million) & (2027-2032) Table 100. China Candidiasis Drug Revenue by Type (2021-2026) & (US$ Million) Table 101. China Candidiasis Drug Revenue by Type (2027-2032) & (US$ Million) Table 102. China Candidiasis Drug Revenue by Application (2021-2026) & (US$ Million) Table 103. China Candidiasis Drug Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Candidiasis Drug Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Candidiasis Drug Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Candidiasis Drug Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Candidiasis Drug Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Candidiasis Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Candidiasis Drug Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Candidiasis Drug Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Candidiasis Drug Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Candidiasis Drug Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Candidiasis Drug Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Candidiasis Drug Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Candidiasis Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Candidiasis Drug Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Candidiasis Drug Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Candidiasis Drug Image Figure 2. Global Candidiasis Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Candidiasis Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. External Use Image Figure 6. Other Image Figure 7. Global Candidiasis Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Candidiasis Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Retail Pharmacy Image Figure 11. Other Image Figure 12. Global Candidiasis Drug Market Size (US$ Million) & (2021-2032) Figure 13. Global Candidiasis Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Candidiasis Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Candidiasis Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Candidiasis Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Candidiasis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Candidiasis Drug Revenue Market Share by Type (2021-2032) Figure 20. Global Candidiasis Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Candidiasis Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Candidiasis Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Candidiasis Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Candidiasis Drug Revenue Share by Type (2021-2032) Figure 25. North America Candidiasis Drug Revenue Share by Application (2021-2032) Figure 26. North America Candidiasis Drug Revenue Share by Country (2021-2032) Figure 27. United States Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Candidiasis Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Candidiasis Drug Revenue Share by Type (2021-2032) Figure 32. Europe Candidiasis Drug Revenue Share by Application (2021-2032) Figure 33. Europe Candidiasis Drug Revenue Share by Country (2021-2032) Figure 34. Germany Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Candidiasis Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Candidiasis Drug Revenue Share by Type (2021-2032) Figure 44. China Candidiasis Drug Revenue Share by Application (2021-2032) Figure 45. Asia Candidiasis Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Candidiasis Drug Revenue Share by Type (2021-2032) Figure 47. Asia Candidiasis Drug Revenue Share by Application (2021-2032) Figure 48. Asia Candidiasis Drug Revenue Share by Region (2021-2032) Figure 49. Japan Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Candidiasis Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Candidiasis Drug Revenue Share by Type (2021-2032) Figure 57. SAMEA Candidiasis Drug Revenue Share by Application (2021-2032) Figure 58. SAMEA Candidiasis Drug Revenue Share by Country (2021-2032) Figure 59. Brazil Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Candidiasis Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • External Use
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Bristol-Myers Squibb
  • Cisen Pharmaceutical
  • Effik
  • Kingyork Group
  • Perrigo
  • Bayer
  • Pfizer
  • J & J
  • Sanofi
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Candidiasis Drug Market by Type
  3. 1.2.1 Global Candidiasis Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 External Use
  6. 1.2.4 Other
  7. 1.3 Candidiasis Drug Market by Application
  8. 1.3.1 Global Candidiasis Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Retail Pharmacy
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Candidiasis Drug Market Dynamics
  1. 2.1 Candidiasis Drug Industry Trends
  2. 2.2 Candidiasis Drug Industry Drivers
  3. 2.3 Candidiasis Drug Industry Opportunities and Challenges
  4. 2.4 Candidiasis Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Candidiasis Drug Market Perspective (2021-2032)
  2. 3.2 Global Candidiasis Drug Growth Trends by Region
  3. 3.2.1 Global Candidiasis Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Candidiasis Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Candidiasis Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Candidiasis Drug Revenue by Players
  2. 4.1.1 Global Candidiasis Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Candidiasis Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Candidiasis Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Candidiasis Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Candidiasis Drug Key Players Headquarters & Area Served
  7. 4.4 Global Candidiasis Drug Players, Product Type & Application
  8. 4.5 Global Candidiasis Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Candidiasis Drug Market CR5 and HHI
  11. 4.6.3 2025 Candidiasis Drug Tier 1, Tier 2, and Tier 3
5 Candidiasis Drug Market Size by Type
  1. 5.1 Global Candidiasis Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Candidiasis Drug Revenue by Type (2021-2032)
  3. 5.3 Global Candidiasis Drug Revenue Market Share by Type (2021-2032)
6 Candidiasis Drug Market Size by Application
  1. 6.1 Global Candidiasis Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Candidiasis Drug Revenue by Application (2021-2032)
  3. 6.3 Global Candidiasis Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bristol-Myers Squibb
  2. 7.1.1 Bristol-Myers Squibb Company Information
  3. 7.1.2 Bristol-Myers Squibb Business Overview
  4. 7.1.3 Bristol-Myers Squibb Candidiasis Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bristol-Myers Squibb Candidiasis Drug Product Portfolio
  6. 7.1.5 Bristol-Myers Squibb Recent Developments
  7. 7.2 Cisen Pharmaceutical
  8. 7.2.1 Cisen Pharmaceutical Company Information
  9. 7.2.2 Cisen Pharmaceutical Business Overview
  10. 7.2.3 Cisen Pharmaceutical Candidiasis Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cisen Pharmaceutical Candidiasis Drug Product Portfolio
  12. 7.2.5 Cisen Pharmaceutical Recent Developments
  13. 7.3 Effik
  14. 7.3.1 Effik Company Information
  15. 7.3.2 Effik Business Overview
  16. 7.3.3 Effik Candidiasis Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Effik Candidiasis Drug Product Portfolio
  18. 7.3.5 Effik Recent Developments
  19. 7.4 Kingyork Group
  20. 7.4.1 Kingyork Group Company Information
  21. 7.4.2 Kingyork Group Business Overview
  22. 7.4.3 Kingyork Group Candidiasis Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Kingyork Group Candidiasis Drug Product Portfolio
  24. 7.4.5 Kingyork Group Recent Developments
  25. 7.5 Perrigo
  26. 7.5.1 Perrigo Company Information
  27. 7.5.2 Perrigo Business Overview
  28. 7.5.3 Perrigo Candidiasis Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Perrigo Candidiasis Drug Product Portfolio
  30. 7.5.5 Perrigo Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Candidiasis Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Candidiasis Drug Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Candidiasis Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Candidiasis Drug Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 J & J
  44. 7.8.1 J & J Company Information
  45. 7.8.2 J & J Business Overview
  46. 7.8.3 J & J Candidiasis Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 J & J Candidiasis Drug Product Portfolio
  48. 7.8.5 J & J Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Candidiasis Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Candidiasis Drug Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
  55. 7.10 Teva
  56. 7.10.1 Teva Company Information
  57. 7.10.2 Teva Business Overview
  58. 7.10.3 Teva Candidiasis Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Teva Candidiasis Drug Product Portfolio
  60. 7.10.5 Teva Recent Developments
8 North America
  1. 8.1 North America Candidiasis Drug Revenue (2021-2032)
  2. 8.2 North America Candidiasis Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Candidiasis Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Candidiasis Drug Revenue by Type (2027-2032)
  5. 8.3 North America Candidiasis Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Candidiasis Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Candidiasis Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Candidiasis Drug Revenue by Application (2027-2032)
  9. 8.5 North America Candidiasis Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Candidiasis Drug Revenue by Country
  11. 8.6.1 North America Candidiasis Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Candidiasis Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Candidiasis Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Candidiasis Drug Revenue (2021-2032)
  2. 9.2 Europe Candidiasis Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Candidiasis Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Candidiasis Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Candidiasis Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Candidiasis Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Candidiasis Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Candidiasis Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Candidiasis Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Candidiasis Drug Revenue by Country
  11. 9.6.1 Europe Candidiasis Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Candidiasis Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Candidiasis Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Candidiasis Drug Revenue (2021-2032)
  2. 10.2 China Candidiasis Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Candidiasis Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Candidiasis Drug Revenue by Type (2027-2032)
  5. 10.3 China Candidiasis Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Candidiasis Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Candidiasis Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Candidiasis Drug Revenue by Application (2027-2032)
  9. 10.5 China Candidiasis Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Candidiasis Drug Revenue (2021-2032)
  2. 11.2 Asia Candidiasis Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Candidiasis Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Candidiasis Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Candidiasis Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Candidiasis Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Candidiasis Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Candidiasis Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Candidiasis Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Candidiasis Drug Revenue by Country
  11. 11.6.1 Asia Candidiasis Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Candidiasis Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Candidiasis Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Candidiasis Drug Revenue (2021-2032)
  2. 12.2 SAMEA Candidiasis Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Candidiasis Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Candidiasis Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Candidiasis Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Candidiasis Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Candidiasis Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Candidiasis Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Candidiasis Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Candidiasis Drug Revenue by Country
  11. 12.6.1 SAMEA Candidiasis Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Candidiasis Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Candidiasis Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst